Type II transmembrane serine proteases in development and disease

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 6-7, 2008, Pages 1297-1316

  Szabo, Roman ^a   Bugge, Thomas H ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Cancer; Cell surface proteolysis; Mammalian development

Indexed keywords

CELL SURFACE PROTEIN; CORIN PROTEASE; ENTEROPEPTIDASE; HEPSIN; HUMAN AIRWAY TRYPSIN LIKE PROTEASE; MATRIPTASE; PROTEINASE; SCATTER FACTOR; SERINE PROTEINASE; TYPE II TRANSMEMBRANE SERINE PROTEASE;

AMINO ACID SEQUENCE; CANCER CLASSIFICATION; ENZYME ANALYSIS; GENE EXPRESSION; GENETIC CODE; GENOMICS; HOMEOSTASIS; HUMAN; NEOPLASM; NONHUMAN; ORGANOGENESIS; PROTEIN EXPRESSION; REVIEW; TISSUE;

ANIMALS; DISEASE; EMBRYOLOGY; FORECASTING; HOMEOSTASIS; HUMAN DEVELOPMENT; HUMANS; MICE; NEOPLASMS; SERINE ENDOPEPTIDASES;

MAMMALIA;

EID: 43049128477     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.11.013     Document Type: Review

References (181)

1. Afar D.E.H., Vivanco I., Hubert R.S., Kuo J., Chen E., Saffran D.C., et al. Catalytic cleavage of the androgen regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Research 61 (2001) 1686-1692
2. Ahmed Z.M., Li X.C., Powell S.D., Riazuddin S., Young T.L., Ramzan K., et al. Characterization of a new full length TMPRSS3 isoform and identification of mutant alleles responsible for nonsyndromic recessive deafness in Newfoundland and Pakistan. BMC Medical Genetics 5 (2004) 24
3. Aimes R.T., Zijlstra A., Hooper J.D., Ogbourne S.M., Sit M.L., Fuchs S., et al. Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thrombosis and Haemostasis 89 (2003) 561-572
4. Andreasen D., Vuagniaux G., Fowler-Jaeger N., Hummler E., and Rossier B.C. Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1. Journal of the American Society of Nephrology 17 (2006) 968-976
5. Basel-Vanagaite L., Attia R., Ishida-Yamamoto A., Rainshtein L., Ben Amitai D., Lurie R., et al. Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase. American Journal of Human Genetics 80 (2007) 467-477
6. Beaufort N., Leduc D., Eguchi H., Mengele K., Hellmann D., Masegi T., et al. The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions. American Journal Physiology-Lung Cellular and Molecular Physiology 292 (2007) L1263-L1272
7. Behrens M., Bufe B., Schmale H., and Meyerhof W. Molecular cloning and characterisation of DESC4, a new transmembrane serine protease. Cellular and Molecular Life Sciences 61 (2004) 2866-2877
8. Ben-Yosef T., Wattenhofer M., Riazuddin S., Ahmed Z.M., Scot H.S., Kudoh J., et al. Novel mutations of TMPRSS3 in four DFNB8/B10 families segregating congenital autosomal recessive deafness. Journal of Medical Genetics 38 (2001) 396-400
9. Betsunoh H., Mukai S., Akiyama Y., Fukushima T., Minamiguchi N., Hasui Y., et al. Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma. Cancer Science 98 (2007) 491-498
10. Bhatt A.S., Erdjument-Bromage H., Tempst P., Craik C.S., and Moasser M.M. Adhesion signaling by a novel mitotic substrate of src kinases. Oncogene 24 (2005) 5333-5343
11. Bhatt A.S., Welm A., Farady C.J., Vasquez M., Wilson K., and Craik C.S. Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 5771-5776
12. Bicknell A.B., Lomthaisong K., Woods R.J., Hutchinson E.G., Bennett H.P.J., Gladwell R.T., et al. Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 105 (2001) 903-912
13. Bleyl S., Nelson L., Odelberg S.J., Ruttenberg H.D., Otterud B., Leppert M., et al. A gene for familial total anomalous pulmonary venous return maps to chromosome 4P13-Q12. American Journal of Human Genetics 56 (1995) 408-415
14. Bottcher E., Matrosovich T., Beyerle M., Klenk H.D., Garten W., and Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. Journal of Virology 80 (2006) 9896-9898
15. Cal S., Peinado J.R., Llamazares M., Quesada V., Moncada-Pazos A., Garabaya C., et al. Identification and characterization of human polyserase-3, a novel protein with tandem serine-protease domains in the same polypeptide chain. BMC Biochemistry 7 (2006) 9
16. Cal S., Quesada V., Garabaya C., and Lopez-Otin C. Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 9185-9190
17. Cal S., Quesada V., Llamazares M., Diaz-Perales A., Garabaya C., and Lopez-Otin C. Human polyserase-2, a novel enzyme with three tandem serine protease domains in a single polypeptide chain. Journal of Biological Chemistry 280 (2005) 1953-1961
18. Carlsson H., Petersson S., and Enerback C. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. International Journal of Oncology 27 (2005) 1473-1481
19. Carney T.J., Von Der Hardt S., Sonntag C., Amsterdam A., Topczewski J., Hopkins N., et al. Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis. Development 134 (2007) 3461-3471
20. Chan J.C.Y., Knudson O., Wu F.Y., Morser J., Dole W.P., and Wu Q.Y. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 785-790
21. Chang S.S., Grunder S., Hanukoglu A., Rosler A., Mathew P.M., Hanukoglu I., et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nature Genetics 12 (1996) 248-253
22. Chen C.H., Su K.Y., Tao M.H., Lin S.W., Su Y.H., Tsai Y.C., et al. Decreased expressions of hepsin in human hepatocellular carcinomas. Liver International 26 (2006) 774-780
23. Chen Z.X., Fan Z.B., Mcneal J.E., Nolley R., Caldwell M.C., Mahadevappa M., et al. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. Journal of Urology 169 (2003) 1316-1319
24. Cho E.G., Kim M.G., Kim C., Kim S.R., Seong I.S., Chung C., et al. N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease. Journal of Biological Chemistry 276 (2001) 44581-44589
25. Chokki M., Yamamura S., Eguchi H., Masegi T., Horiuchi H., Tanabe H., et al. Human airway trypsin-like protease increases mucin gene expression in airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology 30 (2004) 470-478
26. Dhanasekaran S.M., Barrette T.R., Ghosh D., Shah R., Varambally S., Kurachi K., et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412 (2001) 822-826
27. Dries D.L., Victor R.G., Rame J.E., Cooper R.S., Wu X.D., Zhu X.F., et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 112 (2005) 2403-2410
28. Eggermont E., Molla A.M., Tytgat G., and Rutgeerts L. Distribution of enterokinase activity in the human intestine. Acta Gastro-enterologica Belgica 34 (1971) 655-662
29. Elbracht M., Senderek J., Eggermann T., Thurmer C., Park J., Westhofen M., et al. Autosomal recessive postlingual hearing loss (DFNB8): Compound heterozygosity for two novel TMPRSS3 mutations in German siblings. Journal of Medical Genetics 44 (2007) e81
30. Elias P.M. Epidermal barrier function-Intercellular lamellar lipid structures, origin, composition and metabolism. Journal of Controlled Release 15 (1991) 199-208
31. Epp N., Furstenberger G., Muller K., De Juanes S., Leitges M., Hausser I., et al. 12R-lipoxygenase deficiency disrupts epidermal barrier function. Journal of Cell Biology 177 (2007) 173-182
32. Fan B., Brennan J., Grant D., Peale F., Rangell L., and Kirchhofer D. Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth. Developmental Biology 303 (2007) 222-230
33. Fonseca P., and Light A. The purification and characterization of bovine enterokinase from membrane fragments in the duodenal mucosal fluid. Journal of Biological Chemistry 258 (1983) 14516-14520
34. Ge W.T., Hu H.G., Ding K.F., Sun L.F., and Zheng S. Protein interaction analysis of ST14 domains and their point and deletion mutants. Journal of Biological Chemistry 281 (2006) 7406-7412
35. Ghishan F.K., Lee P.C., Lebenthal E., Johnson P., Bradley C.A., and Greene H.L. Isolated congenital enterokinase deficiency-Recent findings and review of the literature. Gastroenterology 85 (1983) 727-731
36. Grant D. Acute necrotising pancreatitis-A role for enterokinase. International Journal of Pancreatology 1 (1986) 167-183
37. Green J.R., Bender S.W., Posselt H.G., and Lentze M.J. Primary intestinal enteropeptidase deficiency. Journal of Pediatric Gastroenterology and Nutrition 3 (1984) 630-633
38. Guipponi M., Tan J., Cannon P.Z., Donley L., Crewther P., Clarke M., et al. Mice deficient for the type II transmembrane serine protease, TMPRSS1/hepsin, exhibit profound hearing loss. American Journal of Pathology 171 (2007) 608-616
39. Guipponi M., Vuagniaux G., Wattenhofer M., Shibuya K., Vazquez M., Dougherty L., et al. The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro. Human Molecular Genetics 11 (2002) 2829-2836
40. Hahner S., Fassnacht M., Hammer F., Schammann M., Weismann D., Hansen I.A., et al. Evidence against a role of human airway trypsin-like protease - The human analogue of the growth-promoting rat adrenal secretory protease - In adrenal tumourigenesis. European Journal of Endocrinology 152 (2005) 143-153
41. Hansen I.A., Fassnacht M., Hahner S., Hammer F., Schammann M., Meyer S.R., et al. The adrenal secretory serine protease AsP is a short secretory isoform of the transmembrane airway trypsin-like protease. Endocrinology 145 (2004) 1898-1905
42. Hartikainen J.M., Tuhkanen H., Kataja V., Eskelinen M., Uusitupa M., Kosma V.M., et al. Refinement of the 22q12-q13 breast cancer-associated region: Evidence of TMPRSS6 as a candidate gene in an eastern Finnish population. Clinical Cancer Research 12 (2006) 1454-1462
43. Haworth J.C., Hadorn B., Gourley B., Prasad A., and Troesch V. Intestinal enterokinase deficiency-Occurrence in 2 sibs and age dependency of clinical expression. Archives of Disease in Childhood 50 (1975) 277-282
44. Hermon-Taylor J., Perrin J., Grant D.A.W., Appleyard A., Bubel M., and Magee A.I. Immunofluorescent localization of enterokinase in human small-intestine. Gut 18 (1977) 259-265
45. Herrmann T., Van Der Hoeven F., Grone H.J., Stewart A.F., Langbein L., Kaiser I., et al. Mice with targeted disruption of the fatty acid transport protein 4 (Fatp 4, SlC27a4) gene show features of lethal restrictive dermopathy. Journal of Cell Biology 161 (2003) 1105-1115
46. Herter S., Piper D.E., Aaron W., Gabriele T., Cutler G., Cao P., et al. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochemical Journal 390 (2005) 125-136
47. Hoang C.D., D'cunha J., Kratzke M.G., Casmey C.E., Frizelle S.P., Maddaus M.A., et al. Gene expression profiling identifies matriptase overexpression in malignant mesothelioma. Chest 125 (2004) 1843-1852
48. Hobson J.P., Netzel-Arnett S., Szabo R., Rehault S.M., Church F.C., Strickland D.K., et al. Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes. Journal of Biological Chemistry 279 (2004) 46981-46994
49. Holzinger A., Maier E.M., Buck C., Mayerhofer P.U., Kappler M., Haworth J.C., et al. Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency. American Journal of Human Genetics 70 (2002) 20-25
50. Hooper J.D., Campagnolo L., Goodarzi G., Truong T.N., Stuhlmann H., and Quigley J.P. Mouse matriptase-2: Identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues. Biochemical Journal 373 (2003) 689-702
51. Hooper J.D., Clements J.A., Quigley J.P., and Antalis T.M. Type II transmembrane serine proteases-Insights into an emerging class of cell surface proteolytic enzymes. Journal of Biological Chemistry 276 (2001) 857-860
52. Hooper J.D., Scarman A.L., Clarke B.E., Normyle J.F., and Antalis T.M. Localization of the mosaic transmembrane serine protease corin to heart myocytes. European Journal of Biochemistry 267 (2000) 6931-6937
53. Iacobuzio-Donahue C.A., Maitra A., Olsen M., Lowe A.W., Van Heek N.T., Rosty C., et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. American Journal of Pathology 162 (2003) 1151-1162
54. Imamura T., and Kitamoto Y. Expression of enteropeptidase in differentiated enterocytes, goblet cells, and the tumor cells in human duodenum. American Journal of Physiology-Gastrointestinal and Liver Physiology 285 (2003) G1235-G1241
55. Irvine A.D., O'regan G.M., Lewis-Jones M.S., Arseculeratne G., Munro C.S., Sergeant A., et al. Mutations in the filaggrin gene cause ichthyosis vulgaris. British Journal of Dermatology 155 (2006) 3-13
56. Irving P., Troxler L., Heuer T.S., Belvin M., Kopczynski C., Reichhart J.M., et al. A genome-wide analysis of immune responses in Drosophila. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 15119-15124
57. Iwakiri K., Ghazizadeh M., Jin E.J., Fujiwara M., Takemura T., Takezaki S., et al. Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. Journal of Investigative Dermatology 122 (2004) 937-944
58. Iyngkaran N., Yadav M., and Boey C.G. Mucosal enterokinase activity in cow's milk protein sensitive enteropathy. Singapore Medical Journal 36 (1995) 393-396
59. Jacquinet E., Rao N.V., Rao G.V., and Hoidal J.R. Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: Epitheliasin. FEBS Letters 468 (2000) 93-100
60. Jacquinet E., Rao N.V., Rao G.V., Wang Z.M., Albertine K.H., and Hoidal J.R. Cloning and characterization of the cDNA and gene for human epitheliasin. European Journal of Biochemistry 268 (2001) 2687-2699
61. Jin J.S., Cheng T.F., Tsai W.C., Sheu L.F., Chiang H., and Yu C.P. Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women: Correlation with clinicopathological parameters. Histology and Histopathology 22 (2007) 305-309
62. Jin J.S., Hsieh D.S., Loh S.H., Chen A., Yao C.W., and Yen C.Y. Increasing expression of serine protease matriptase in ovarian tumors: Tissue microarray analysis of immunostaining score with clinicopathological parameters. Modern Pathology 19 (2006) 447-452
63. Jobard F., Lefevre C., Karaduman A., Blanchet-Bardon C., Emre S., Weissenbach J., et al. Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1. Human Molecular Genetics 11 (2002) 107-113
64. Kang J.Y., Dolled-Filhart M., Ocal I.T., Singh B., Lin C.Y., Dickson R.B., et al. Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Research 63 (2003) 1101-1105
65. Kazama Y., Hamamoto T., Foster D.C., and Kisiel W. Hepsin, a putative membrane-associated serine-protease, activates human factor-VII and initiates a pathway of blood-coagulation on the cell-surface leading to thrombin formation. Journal of Biological Chemistry 270 (1995) 66-72
66. Kebebew E., Peng M., Reiff E., Duh Q.Y., Clark O.H., and Mcmillan A. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Annals of Surgery 242 (2005) 353-363
67. Kebebew E., Peng M., Reiff E., and Mcmillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 106 (2006) 2592-2597
68. Kelsell D.P., Norgett E.E., Unsworth H., Teh M.T., Cullup T., Mein C.A., et al. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. American Journal of Human Genetics 76 (2005) 794-803
69. Kilpatrick L.M., Harris R.L., Owen K.A., Bass R., Ghorayeb C., Bar-or A., et al. Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood 108 (2006) 2616-2623
70. Kim D.R., Sharmin S., Inoue M., and Kido H. Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung. Biochimica Et Biophysica Acta-Gene Structure and Expression 1518 (2001) 204-209
71. Kim M.G., Chen C., Lyu M.S., Cho E.G., Park D., Kozak C., et al. Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains. Immunogenetics 49 (1999) 420-428
72. Kim T.S., Heinlein C., Hackman R.C., and Nelson P.S. Phenotypic analysis of mice lacking the Tmprss2-encoded protease. Molecular and Cellular Biology 26 (2006) 965-975
73. Kirchhofer D., Peek M., Li W., Stamos J., Eigenbrot C., Kadkhodayan S., et al. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator Inhibitor-1B (HAI-1B), a new splice variant of HAI-1. Journal of Biological Chemistry 278 (2003) 36341-36349
74. Kirchhofer D., Peek M., Lipari M.T., Billeci K., Fan B., and Moran P. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Letters 579 (2005) 1945-1950
75. Kishi K., Yamazaki K., Yasuda I., Yahagi N., Ichinose M., Tsuchiya Y., et al. Characterization of a membrane-bound arginine-specific serine protease from rat intestinal mucosa. Journal of Biochemistry 130 (2001) 425-430
76. Kitamoto Y., Yuan X., Wu Q.Y., Mccourt D.W., and Sadler J.E. Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains. Proceedings of the National Academy of Sciences of the United States of America 91 (1994) 7588-7592
77. Klezovitch O., Chevillet J., Mirosevich J., Roberts R.L., Matusik R.J., and Vasioukhin V. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6 (2004) 185-195
78. Knappe S., Wu F., Madlansacay M.R., and Wu Q. Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide. The Journal of Biological Chemistry 279 (2004) 34464-34471
79. Knappe S., Wu F., Masikat M.R., Morser J., and Wu Q. Functional analysis of the transmembrane domain and activation cleavage of human corin: Design and characterization of a soluble corin. The Journal of Biological Chemistry 278 (2003) 52363-52370
80. Lang J.C., and Schuller D.E. Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck. British Journal of Cancer 84 (2001) 237-243
81. Lebenthal E., Antonowicz I., and Shwachman H. Enterokinase and trypsin activities in pancreatic insufficiency and diseases of the small intestine. Gastroenterology 70 (1976) 508-512
82. Lee J.W., Song S.Y., Choi J.J., Lee S.J., Kim B.G., Park C.S., et al. Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. Human Pathology 36 (2005) 626-633
83. Lee S.L., Dickson R.B., and Lin C.Y. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. Journal of Biological Chemistry 275 (2000) 36720-36725
84. Levitin F., Stern O., Weiss M., Gil-Henn C., Ziv R., Prokocimer Z., et al. The MUC1 SEA module is a self-cleaving domain. Journal of Biological Chemistry 280 (2005) 33374-33386
85. Leytus S.P., Loeb K.R., Hagen F.S., Kurachi K., and Davie E.W. A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human-liver and hepatoma-cells. Biochemistry 27 (1988) 1067-1074
86. Leyvraz C., Charles R.P., Rubera I., Guitard M., Rotman S., Breiden B., et al. The epidermal barrier function is dependent on the serine protease CAP1/Prss8. Journal of Cell Biology 170 (2005) 487-496
87. Lin B.Y., Ferguson C., White J.T., Wang S.Y., Vessella R., True L.D., et al. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Research 59 (1999) 4180-4184
88. Lin C.Y., Anders J., Johnson M., and Dickson R.B. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. Journal of Biological Chemistry 274 (1999) 18237-18242
89. Lin C.Y., Anders J., Johnson M., Sang Q.A., and Dickson R.B. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. Journal of Biological Chemistry 274 (1999) 18231-18236
90. Lin C.Y., Wang J.K., Torri J., Dou L., Sang Q.X.A., and Dickson R.B. Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells - Monoclonal antibody production, isolation, and localization. Journal of Biological Chemistry 272 (1997) 9147-9152
91. List K., Currie B., Scharschmidt T.C., Szabo R., Shireman J., Molinolo A., et al. Autosomal Ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice. Journal of Biological Chemistry 282 (2007) 36714-36723
92. List K., Haudenschild C.C., Szabo R., Chen W.J., Wahl S.M., Swaim W., et al. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21 (2002) 3765-3779
93. List K., Hobson J.P., Molinolo A., and Bugge T.H. Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase. Journal of Cell Physiology 213 (2007) 237-245
94. List K., Szabo R., Molinolo A., Nielsen B.S., and Bugge T.H. Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. American Journal of Pathology 168 (2006) 1513-1525
95. List K., Szabo R., Molinolo A., Sriuranpong V., Redeye V., Murdock T., et al. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes & Development 19 (2005) 1934-1950
96. List K., Szabo R., Wertz P.W., Segre J., Haudenschild C.C., Kim S.Y., et al. Loss of proteolytically processed filaggrin caused by epidermal deletion of matriptase/MT-SP1. Journal of Cell Biology 163 (2003) 901-910
97. Louvard D., Maroux S., Baratti J., and Desnuell P. Distribution of enterokinase in porcine intestine and on its subcellular localization. Biochimica Et Biophysica Acta 309 (1973) 127-137
98. Lu D.S., Yuan X., Zheng X.L., and Sadler J.E. Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain. Journal of Biological Chemistry 272 (1997) 31293-31300
99. Luo J., Duggan D.J., Chen Y.D., Sauvageot J., Ewing C.M., Bittner M.L., et al. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Research 61 (2001) 4683-4688
100. Macao B., Johansson D.G., Hansson G.C., and Hard T. Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nature Structural & Molecular Biology 13 (2006) 71-76
101. Magee J.A., Araki T., Patil S., Ehrig T., True L., Humphrey P.A., et al. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Research 61 (2001) 5692-5696
102. Mann N.S., and Mann S.K. Enterokinase. Proceedings of the Society for Experimental Biology and Medicine 206 (1994) 114-118
103. Maroux S., Baratti J., and Desnuell P. Purification and specificity of porcine enterokinase. Journal of Biological Chemistry 246 (1971) 5031
104. Masmoudi S., Antonarakis S.E., Schwede T., Ghorbel A.M., Gratri M., Pappasavas M.P., et al. Novel missense mutations of TMPRSS3 in two consanguineous Tunisian families with non-syndromic autosomal recessive deafness. Human Mutation 18 (2001) 101-108
105. Matsushima M., Ichinose M., Yahagi N., Kakei N., Tsukada S., Miki K., et al. Structural characterization of porcine enteropeptidase. Journal of Biological Chemistry 269 (1994) 19976-19982
106. Matsushima R., Takahashi A., Nakaya Y., Maezawa H., Miki M., Nakamura Y., et al. Human airway trypsin-like protease stimulates human bronchial fibroblast proliferation in a protease-activated receptor-2-dependent pathway. American Journal of Physiology-Lung Cellular and Molecular Physiology 290 (2006) L385-L395
107. McMahon A., Butovich I.A., Mata N.L., Klein M., Ritter III R., Richardson J., et al. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Molecular Vision 13 (2007) 258-272
108. Miki M., Nakamura Y., Takahashi A., Nakaya Y., Eguchi H., Masegi T., et al. Effect of human airway trypsin-like protease on intracellular free Ca2+ concentration in human bronchial epithelial cells. The Journal of Medical Investigation 50 (2003) 95-107
109. Moran P., Li W., Fan B., Vij R., Eigenbrot C., and Kirchhofer D. Pro-urokinase-type plasminogen activator is a substrate for hepsin. Journal of Biological Chemistry 281 (2006) 30439-30446
110. Moroz S.P., Hadorn B., Rossi T.M., and Haworth J.C. Celiac disease in a patient with a congenital deficiency of intestinal enteropeptidase. American Journal of Gastroenterology 96 (2001) 2251-2254
111. Netzel-Arnett S., Currie B.M., Szabo R., Lin C.Y., Chen L.M., Chai K.X., et al. Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. Journal of Biological Chemistry 281 (2006) 32941-32945
112. Netzel-Arnett S., Hooper J.D., Szabo R., Madison E.L., Quigley J.P., Bugge T.H., et al. Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer and Metastasis Reviews 22 (2003) 237-258
113. Nordstro C., and Dahlqvis A. Localization of human enterokinase. Lancet 2 (1972) 933
114. Oberst M., Anders J., Xie B., Singh B., Ossandon M., Johnson M., et al. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. American Journal of Pathology 158 (2001) 1301-1311
115. Oberst M.D., Johnson M.D., Dickson R.B., Lin C.Y., Singh B., Stewart M., et al. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: Correlation with clinical outcome and tumor clinicopathological parameters. Clinical Cancer Research 8 (2002) 1101-1107
116. Oberst M.D., Singh B., Ozdemirli M., Dickson R.B., Johnson M.D., and Lin C.Y. Characterization of matriptase expression in normal human tissues. Journal of Histochemistry & Cytochemistry 51 (2003) 1017-1025
117. Oberst M.D., Williams C.A., Dickson R.B., Johnson M.D., and Lin C.Y. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. Journal of Biological Chemistry 278 (2003) 26773-26779
118. Okumura Y., Hayama M., Takahashi E., Fujiuchi M., Shimabukuro A., Yano M., et al. Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans. Biochemical Journal 400 (2006) 551-561
119. Omer S., Lomthaisong K., and Bicknell A.B. Identification of two alternate splice variants of a novel serine protease expressed in steroidogenic tissues. Endocrine Research 28 (2002) 339-348
120. Pal P., Xi H., Kaushal R., Sun G., Jin C.H., Jin L., et al. Variants in the HEPSIN gene are associated with prostate cancer in men of European origin. Human Genetics 120 (2006) 187-192
121. Paoloni-Giacobino A., Chen H.M., Peitsch M.C., Rossier C., and Antonarakis S.E. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics 44 (1997) 309-320
122. Peters T.A., Levtchenko E., Cremers C.W.R.J., Curfs J.H.A.J., and Monnens L.A.H. No evidence of hearing loss in pseudohypoaldosteronism type 1 patients. Acta Oto-Laryngologica 126 (2006) 237-239
123. Petrovics G., Liu A.J., Shaheduzzaman S., Furasato B., Sun C., Chen Y.M., et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24 (2005) 3847-3852
124. Puente X.S., Sanchez L.M., Gutierrez-Fernandez A., Velasco G., and Lopez-Otin C. A genomic view of the complexity of mammalian proteolytic systems. Biochemical Society Transactions 33 (2005) 331-334
125. Puente X.S., Sanchez L.M., Overall C.M., and Lopez-Otin C. Human and mouse proteases: A comparative genomic approach. Nature Reviews Genetics 4 (2003) 544-558
126. Qiu D., Owen K., Gray K., Bass R., and Ellis V. Roles and regulation of membrane-associated serine proteases. Biochemical Society Transactions 35 (2007) 583-587
127. Rawlings N.D., Morton F.R., and Barrett A.J. MEROPS: The peptidase database. Nucleic Acids Research 34 (2006) D270-D272
128. Riddick A.C.P., Shukla C.J., Pennington C.J., Bass R., Nuttall R.K., Hogan A., et al. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. British Journal of Cancer 92 (2005) 2171-2180
129. Rinderknecht H., Nagaraja M.R., and Adham N.F. Enteropeptidase Levels in Duodenal Juice of Normal Subjects and Patients with Gastrointestinal-Disease. American Journal of Digestive Diseases 23 (1978) 327-331
130. Roemer A., Schwettmann L., Jung M., Stephan C., Roigas J., Kristiansen G., et al. The membrane proteases ADAMS and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?. Journal of Urology 172 (2004) 2162-2166
131. Rutgeert L., and Eggermon E. Human enterokinase. Tijdschr Gastroenterol 19 (1976) 231-246
132. Saleem M., Adhami V.M., Zhong W.X., Longley B.J., Lin C.Y., Dickson R.B., et al. A novel biomarker for staging human prostate adenocarcinoma: Overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiology Biomarkers & Prevention 15 (2006) 217-227
133. Santin A.D., Zhan F.H., Bellone S., Palmieri M., Cane S., Bignotti E., et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy. International Journal of Cancer 112 (2004) 14-25
134. Satomi S., Yamasaki Y., Tsuzuki S., Hitomi Y., Iwanaga T., and Fushiki T. A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover. Biochemical and Biophysical Research Communications 287 (2001) 995-1002
135. Sawasaki T., Shigemasa K., Gu L.J., Beard J.B., and O'brien T.J. The transmembrane protease serine (TMPRSS3/TADG-12) D variant: A potential candidate for diagnosis and therapeutic intervention in ovarian cancer. Tumor Biology 25 (2004) 141-148
136. Schultz J., Milpetz F., Bork P., and Ponting C.P. SMART, a simple modular architecture research tool: Identification of signaling domains. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 5857-5864
137. Scott H.S., Kudoh J., Wattenhofer M., Shibuya K., Berry A., Chrast R., et al. Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nature Genetics 27 (2001) 59-63
138. Sedghizadeh P.P., Mallery S.R., Thompson S.J., Kresty L., Beck F.M., Parkinson E.K., et al. Expression of the serine protease Desc1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck 28 (2006) 432-440
139. Shi Y.E., Torri J., Yieh L., Wellstein A., Lippman M.E., and Dickson R.B. Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast-cancer cells. Cancer Research 53 (1993) 1409-1415
140. Smith F.J.D., Irvine A.D., Terron-Kwiatkowski A., Sandilands A., Campbell L.E., Zhao Y.W., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nature Genetics 38 (2006) 337-342
141. Soller M.J., Elfving P., Lundgren R., and Panagopols I. Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer. Genes Chromosomes & Cancer 45 (2006) 717-719
142. Stamey T.A., Warrington J.A., Caldwell M.C., Chen Z.X., Fan Z.B., Mahadevappa M., et al. Molecular genetic profiling of gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. Journal of Urology 166 (2001) 2171-2177
143. Stephan C., Yousef G.M., Scorilas A., Jung K., Jung M., Kristiansen G., et al. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. Journal of Urology 171 (2004) 187-191
144. Szabo R., Molinolo A., List K., and Bugge T.H. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 26 (2007) 1546-1556
145. Szabo R., Netzel-Arnett S., Hobson J.P., Antalis T.M., and Bugge T.H. Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity. Biochemical Journal 390 (2005) 231-242
146. Szabo R., Wu Q.Y., Dickson R.B., Netzel-Arnett S., Antalis T.M., and Bugge T.H. Type II transmembrane serine proteases. Thrombosis and Haemostasis 90 (2003) 185-193
147. Takahashi M., Sano T., Yamaoka K., Kamimura T., Umemoto N., Nishitani H., et al. Localization of human airway trypsin-like protease in the airway: An immunohistochemical study. Histochemistry and Cell Biology 115 (2001) 181-187
148. Takeuchi T., Harris J.L., Huang W., Yan K.W., Coughlin S.R., and Craik C.S. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. Journal of Biological Chemistry 275 (2000) 26333-26342
149. Takeuchi T., Shuman M.A., and Craik C.S. Reverse biochemistry: Use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 11054-11061
150. Tanaka H., Nagaike K., Takeda N., Itoh H., Kohama K., Fukushima T., et al. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Molecular and Cellular Biology 25 (2005) 5687-5698
151. Tanimoto H., Yan Y., Clarke J., Korourian S., Shigemasa K., Parmley T.H., et al. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Research 57 (1997) 2884-2887
152. Tomlins S.A., Mehra R., Rhodes D.R., Smith L.R., Roulston D., Helgesson B.E., et al. TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Research 66 (2006) 3396-3400
153. Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.W., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648
154. Tozlu S., Girault I., Vacher S., Vendrell J., Andrieu C., Spyratos F., et al. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocrine-Related Cancer 13 (2006) 1109-1120
155. Tran K.L., Lu X.G., Lei M., Feng Q.P., and Wu Q.Y. Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium. American Journal of Physiology-Heart and Circulatory Physiology 287 (2004) H1625-H1631
156. Tsuji A., Torresrosado A., Arai T., Lebeau M.M., Lemons R.S., Chou S.H., et al. Hepsin, a cell membrane-associated protease-Characterization, tissue distribution, and gene localization. Journal of Biological Chemistry 266 (1991) 16948-16953
157. Uhland K. Matriptase and its putative role in cancer. Cellular and Molecular Life Sciences 63 (2006) 2968-2978
158. Vaarala M.H., Porvari K., Kyllonen A., Lukkarinen O., and Vihko P. The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: Detection of mutated TMPRSS2 form in a case of aggressive disease. International Journal of Cancer 94 (2001) 705-710
159. Vaarala M.H., Porvari K.S., Kellokumpu S., Kyllonen A.P., and Vihko P.T. Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues. Journal of Pathology 193 (2001) 134-140
160. Velasco G., Cal S., Quesada V., Sanchez L.M., and Lopez-Otin C. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. Journal of Biological Chemistry 277 (2002) 37637-37646
161. Vogel L.K., Saebo M., Skjelbred C.F., Abell K., Pedersen E.D.K., Vogel U., et al. The ratio of Matriptase/HAI-l mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. Bmc Cancer 6 (2006)
162. Vu T.K.H., Liu R.W., Haaksma C.J., Tomasek J.J., and Howard E.W. Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos. Journal of Biological Chemistry 272 (1997) 31315-31320
163. Wallrapp C., Hahnel S., Muller-Pillasch F., Burghardt B., Iwamura T., Ruthenburger M., et al. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Research 60 (2000) 2602-2606
164. Watanabe Y., Okui A., Mitsui S., Kawarabuki K., Yamaguchi T., Uemura H., et al. Molecular cloning and tissue-specific expression analysis of mouse spinesin, a type II transmembrane serine protease 5. Biochemical and Biophysical Research Communications 324 (2004) 333-340
165. Wattenhofer M., Di Iorio M.V., Rabionet R., Dougherty L., Pampanos A., Schwede T., et al. Mutations in the TMPRSS3 gene are a rare cause of childhood nonsyndromic deafness in Caucasian patients. Journal of Molecular Medicine 80 (2002) 124-131
166. Wattenhofer M., Sahin-Calapoglu N., Andreasen D., Kalay E., Caylan R., Braillard B., et al. A novel TMPRSS3 missense mutation in a DFNB8/10 family prevents proteolytic activation of the protein. Human Genetics 117 (2005) 528-535
167. Wu Q.Y. Type II transmembrane serine proteases. Cell Surface Proteases 54 (2003) 167-206
168. Wu Q.Y. The serine protease corin in cardiovascular biology and disease. Frontiers in Biosciences 12 (2007) 4179-4190
169. Wu Q.Y., Yu D.Y., Post J., Halks-Miller M., Sadler J.E., and Morser J. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. Journal of Clinical Investigation 101 (1998) 321-326
170. Yamaguchi N., Okui A., Yamada T., Nakazato H., and Mitsui S. Spinesin/TMPRSS5, a novel transmembrane serine protease, cloned from human spinal cord. Journal of Biological Chemistry 277 (2002) 6806-6812
171. Yamaoka K., Masuda K., Ogawa H., Takagi K., Umemoto N., and Yasuoka S. Cloning and characterization of the cDNA for human airway trypsin-like protease. Journal of Biological Chemistry 273 (1998) 11895-11901
172. Yan W., Sheng N., Seto M., Morser J., and Wu Q.Y. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. Journal of Biological Chemistry 274 (1999) 14926-14935
173. Yan W., Wu F.Y., Morser J., and Wu Q.Y. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 8525-8529
174. Yasuoka S., Ohnishi T., Kawano S., Tsuchihashi S., Ogawara M., Masuda K., et al. Purification, characterization, and localization of a novel trypsin-like protease found in the human airway. American Journal of Respiratory Cell and Molecular Biology 16 (1997) 300-308
175. Yoshinaga S., Nakahori Y., and Yasuoka S. Fibrinogenolytic activity of a novel trypsin-like enzyme found in human airway. The Journal of Medical Investigation 45 (1998) 77-86
176. Yu I.S., Chen H.J., Lee Y.S.E., Huang P.H., Lin S.R., Tsai T.W., et al. Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability. Thrombosis and Haemostasis 84 (2000) 865-870
177. Yuan X., Zheng X.L., Lu D.S., Rubin D.C., Pung C.Y.M., and Sadler J.E. Structure of murine enterokinase (enteropeptidase) and expression in small intestine during development. American Journal of Physiology-Gastrointestinal and Liver Physiology 37 (1998) G342-G349
178. Zacharski L.R., Ornstein D.L., Memoli V.A., Rousseau S.M., and Kisiel W. Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thrombosis and Haemostasis 79 (1998) 876-877
179. Zamolodchikova T.S., Sokolova E.A., Lu D.S., and Sadler J.E. Activation of recombinant proenteropeptidase by duodenase. Febs Letters 466 (2000) 295-299
180. Zeng L., Cao J., and Zhang X. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract. World Journal of Gastroenterology 11 (2005) 6202-6207
181. Zou Z., Lopez D.L., Kanost M.R., Evans J.D., and Jiang H.B. Comparative analysis of serine protease-related genes in the honey bee genome: Possible involvement in embryonic development and innate immunity. Insect Molecular Biology 15 (2006) 603-614